Key statistics
On Friday, Innate Pharma SA (IDDA:FRA) closed at 1.40, 2.94% above its 52-week low of 1.36, set on Feb 12, 2026.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 1.41 |
|---|---|
| High | 1.41 |
| Low | 1.40 |
| Bid | 1.37 |
| Offer | 1.42 |
| Previous close | 1.43 |
| Average volume | 0.00 |
|---|---|
| Shares outstanding | 93.74m |
| Free float | 63.69m |
| P/E (TTM) | -- |
| Market cap | 155.16m USD |
| EPS (TTM) | -0.6475 USD |
Data delayed at least 15 minutes, as of Feb 20 2026 14:25 GMT.
More ▼
Press releases
- Number of Shares and Voting Rights of Innate Pharma as of February 19, 2026
- Innate Pharma to Participate in the Leerink Partners Global Healthcare Conference
- Number of Shares and Voting Rights of Innate Pharma as of December 31, 2025
- Number of Shares and Voting Rights of Innate Pharma as of December 18, 2025
- Innate Pharma Releases Its 2026 Financial Calendar
- Number of Shares and Voting Rights of Innate Pharma as of November 27, 2025
More ▼
